Barclays
MDLN

Barclays’s Medline Inc MDLN Stock Holding History

Barclays’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Buy
+68,879
New +$3.04M ﹤0.01% 2107

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Barclays's MDLN Position: Q1 2026 in Review

Barclays opened a new position in Medline Inc (MDLN) in Q1 2026: 68,879 shares worth $3.07M. The stake represents ﹤0.01% of the portfolio and ranks #2107 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Barclays held 68,879 shares of Medline Inc worth $3.07M as of Q1 2026.
  • Medline Inc was a new Barclays position in Q1 2026.
  • Medline Inc made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2107 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.